Align technology receives us fda 510(k) clearance for the invisalign® palatal expander system to address skeletal and dental expansion in growing patients, including teenage patients which represent the majority of orthodontic case starts globally

San jose, calif. & tempe, ariz.--(business wire)--align technology, inc. (“align”) (nasdaq: algn), a leading global medical device company that designs, manufactures, and sells the invisalign® system of clear aligners, itero™ intraoral scanners, and exocad™ cad/cam software for digital orthodontics and restorative dentistry, today announced that the u.s. food and drug administration (fda) has cleared align's invisalign® palatal expander system* for commercial availability in the u.s. the fda 51.
ALGN Ratings Summary
ALGN Quant Ranking